LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 86 filers reported holding LOXO ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $33,702,000 | -27.7% | 240,609 | -11.9% | 0.02% | -13.0% |
| Q3 2018 | $46,645,000 | -6.0% | 273,047 | -4.5% | 0.02% | -8.0% |
| Q2 2018 | $49,613,000 | +74.4% | 285,987 | +16.0% | 0.02% | +78.6% |
| Q1 2018 | $28,441,000 | -31.6% | 246,520 | -50.1% | 0.01% | -30.0% |
| Q4 2017 | $41,594,000 | +16.3% | 494,101 | +27.3% | 0.02% | +11.1% |
| Q3 2017 | $35,752,000 | +17.0% | 388,100 | +1.8% | 0.02% | +20.0% |
| Q2 2017 | $30,560,000 | +15.0% | 381,097 | -39.7% | 0.02% | +15.4% |
| Q1 2017 | $26,573,000 | +200.9% | 631,486 | +129.6% | 0.01% | +160.0% |
| Q4 2016 | $8,832,000 | +22.7% | 275,000 | 0.0% | 0.01% | +25.0% |
| Q3 2016 | $7,200,000 | +12.9% | 275,000 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $6,375,000 | – | 275,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |